These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 19155874

  • 1. On the road to better dyslipidemia outcomes.
    Hughes S.
    Nurse Pract; 2009 Feb; 34(2):14-21; quiz 22. PubMed ID: 19155874
    [No Abstract] [Full Text] [Related]

  • 2. The use of lipid-lowering drug therapy in children and adolescents.
    Avis HJ, Vissers MN, Wijburg FA, Kastelein JJ, Hutten BA.
    Curr Opin Investig Drugs; 2009 Mar; 10(3):224-31. PubMed ID: 19333879
    [Abstract] [Full Text] [Related]

  • 3. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
    Fazio S.
    Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268
    [Abstract] [Full Text] [Related]

  • 4. Drugs for lipids.
    Treat Guidel Med Lett; 2005 Mar; 3(31):15-22. PubMed ID: 15726011
    [No Abstract] [Full Text] [Related]

  • 5. Dyslipidaemia in diabetes.
    Patel J.
    Clin Evid; 2006 Jun; (15):555-75. PubMed ID: 16973026
    [No Abstract] [Full Text] [Related]

  • 6. Is it necessary to add fibrate to statin therapy in the management of dyslipidemia of metabolic syndrome?
    Turhan H, Yetkin E.
    Int J Cardiol; 2006 Jun 16; 110(2):276-7. PubMed ID: 16364471
    [Abstract] [Full Text] [Related]

  • 7. Managing dyslipidemia in chronic kidney disease.
    Harper CR, Jacobson TA.
    J Am Coll Cardiol; 2008 Jun 24; 51(25):2375-84. PubMed ID: 18565393
    [Abstract] [Full Text] [Related]

  • 8. First-line therapies for lowering triglyceride levels.
    Raghavan VA.
    Am Fam Physician; 2008 Feb 15; 77(4):416; author reply 417-8. PubMed ID: 18326158
    [No Abstract] [Full Text] [Related]

  • 9. A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome.
    Davidson M.
    Am J Cardiol; 2008 Dec 22; 102(12A):19L-27L. PubMed ID: 19084086
    [Abstract] [Full Text] [Related]

  • 10. Management of cardiovascular risk associated with insulin resistance, diabetes, and the metabolic syndrome.
    Mehta A.
    Postgrad Med; 2010 May 22; 122(3):61-70. PubMed ID: 20463415
    [Abstract] [Full Text] [Related]

  • 11. Lipid screening and cardiovascular health in childhood.
    Daniels SR, Greer FR, Committee on Nutrition.
    Pediatrics; 2008 Jul 22; 122(1):198-208. PubMed ID: 18596007
    [Abstract] [Full Text] [Related]

  • 12. Utility of currently available modes of therapy in reaching lipid goals.
    Spratt KA, Denke MA.
    J Am Osteopath Assoc; 2004 Sep 22; 104(9 Suppl 7):S14-6. PubMed ID: 15467019
    [Abstract] [Full Text] [Related]

  • 13. Lipid management in the geriatric patient.
    Nair AP, Darrow B.
    Endocrinol Metab Clin North Am; 2009 Mar 22; 38(1):185-206. PubMed ID: 19217519
    [Abstract] [Full Text] [Related]

  • 14. [Therapy of dyslipidemia in post-infarction: state of the art].
    Borgia MC, Nardi M, Da Ros S, Castellano V.
    Clin Ter; 2007 Mar 22; 158(6):523-32. PubMed ID: 18265719
    [Abstract] [Full Text] [Related]

  • 15. Strategies for reducing cardiovascular risk in patients with hypertriglyceridemia.
    Gorkin JU, Watson K, Knopp RH.
    J Fam Pract; 2007 Aug 22; 56(8 Suppl Strategies):S1-7; quiz S8. PubMed ID: 18667138
    [No Abstract] [Full Text] [Related]

  • 16. Hypertriglyceridemia and cardiovascular disease management.
    Codario RA.
    J Am Acad Nurse Pract; 2007 Aug 22; 19(12 Suppl 2):7-10, 13-4. PubMed ID: 18510282
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of lipid disorders in metabolic syndrome and type 2 diabetes. The place for fibrates].
    Cybulska B, Kłosiewicz-Latoszek L.
    Kardiol Pol; 2005 Jun 22; 62 Suppl 2():II45-50. PubMed ID: 19813336
    [No Abstract] [Full Text] [Related]

  • 18. The treatment of dyslipidemia--what's left in the pipeline?
    Rau O, Zettl H, Popescu L, Steinhilber D, Schubert-Zsilavecz M.
    ChemMedChem; 2008 Feb 22; 3(2):206-21. PubMed ID: 17963209
    [Abstract] [Full Text] [Related]

  • 19. [Diabetic dyslipoproteinemia: beyond LDL].
    Merkel M.
    Dtsch Med Wochenschr; 2009 May 22; 134(20):1067-73. PubMed ID: 19421932
    [Abstract] [Full Text] [Related]

  • 20. Statin-fibrate combination therapy.
    Feeman WE.
    Am J Cardiol; 2008 May 15; 101(10):1521. PubMed ID: 18471475
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.